Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=dcthLatest Financial News for Delcath Systems, Inc.en-usTue, 22 Dec 2009 11:30:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091222/sf29405.html?.v=1Delcath Systems, Inc. , a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that Professor Riccardo Lencioni has joined the Company's Scientific Advisory Board, effective immediately.yahoo_finance/153811426Tue, 22 Dec 2009 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1317j1eah/*http%3A//www.fool.com/investing/general/2009/12/16/the-best-investing-ideas-in-health-care.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2267818397Wed, 16 Dec 2009 15:26:23 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12i354c7e/*http%3A//www.marketwatch.com/news/story/fund-manager-taps-growth-gold/story.aspx?guid=%7BD489B74C%2D091D%2D411A%2D985D%2D1F8FE5CB9E22%7D&siteid=yhoofIf you pick stocks for a living, a company's price-to-earnings ratio usually plays a part in your decision to buy or not to buy. But that metric is not always top of mind for Marshall Berol, co-manager with Malcolm Gissen of the Encompass Fund.yahoo_finance/2517274857Fri, 4 Dec 2009 11:03:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=DCTHyahoo_finance/1656491930Mon, 30 Nov 2009 18:16:36 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091124/aq16490.html?.v=1Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, recently sponsored a Satellite Symposium at the World Meeting of Melanoma/Skin Cancer Centers in Berlin, Germany.yahoo_finance/1165270768Tue, 24 Nov 2009 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12oqpjnsp/*http%3A//seekingalpha.com/article/174525-biomed-news-bytes-astrazeneca-delcath-unilife?source=yahooyahoo_finance/2842569188Fri, 20 Nov 2009 13:24:37 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091119/aq14318.html?.v=1Delcath Systems, Inc. , a medical technology company developing the Delcath Percutaneous Hepatic Perfusion (PHP) System, a minimally invasive drug delivery platform for the regional treatment of cancer metastatic to the liver, today reported on the Company's recent progress.yahoo_finance/1718269033Thu, 19 Nov 2009 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091118/us_delcath_share_offering.html?.v=1Delcath Systems Inc., a developer of a cancer-drug delivery device, said Wednesday it raised $32.4 million in net proceeds from a public stock offering.yahoo_finance/3559565448Wed, 18 Nov 2009 20:17:01 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091118/dcth8-k.htmlyahoo_finance/2264573939Wed, 18 Nov 2009 17:59:01 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091118/sf13790.html?.v=1Delcath Systems, Inc. announced today the closing of its public offering of 9,775,000 shares of common stock priced to the public at $3.60 per share.yahoo_finance/1385610446Wed, 18 Nov 2009 17:45:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091116/sf11493.html?.v=1Delcath Systems, Inc. , a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, today announced that its President and CEO Eamonn P.yahoo_finance/413216710Mon, 16 Nov 2009 11:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091113/us_delcath_share_offering.html?.v=1Delcath Systems Inc., maker of a cancer-drug delivery device, said Friday it has priced a public offering of 8.5 million common shares at $3.60 each, for estimated proceeds of $30.6 million.yahoo_finance/3980591703Fri, 13 Nov 2009 17:25:40 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091112/sf10734.html?.v=1Delcath Systems, Inc. announced today that it has priced its public offering of 8.5 million shares of its common stock at $3.60 per share, or $30.6 million, pursuant to an underwriting agreement dated November 12, 2009.yahoo_finance/1048185883Fri, 13 Nov 2009 00:18:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=dcthyahoo_finance/557563359Thu, 29 Oct 2009 13:04:36 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091027/sf99586.html?.v=1Delcath Systems, Inc. announced today that it intends, subject to market and other conditions, to offer up to 8.5 million shares of its common stock in a registered public offering pursuant to its existing shelf registration statement under the Securities Act of 1933.yahoo_finance/1550195424Tue, 27 Oct 2009 10:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091023/sf97772.html?.v=1Delcath Systems, Inc. , a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, completed the expansion of its executive management team with three new hires.yahoo_finance/423010157Fri, 23 Oct 2009 10:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091021/dcth8-k.htmlyahoo_finance/1498954304Wed, 21 Oct 2009 15:26:40 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091021/sf96107.html?.v=1Delcath Systems, Inc. , a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that its pivotal Phase III Metastatic Melanoma Trial has met its goal of 92 patients and is fully enrolled.yahoo_finance/1001445934Wed, 21 Oct 2009 10:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ts/091020/10613561.html?.v=2yahoo_finance/3136335337Tue, 20 Oct 2009 09:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11vdhs024/*http%3A//online.barrons.com/article/SB125513265328177339.html?ru=yahoo&mod=yahoobarrons2009's Big Winners See Slimmer Pickings Ahead A once-in-a-lifetime buying opportunity has passed. But four savvy fund managers still see names worth grabbing.yahoo_finance/4289158040Sat, 10 Oct 2009 11:07:38 Etc/GMT